Segev D - Search Results

1

Public health safety and transplant with increased-risk organs: striking the balance.

Batra R, Katariya N, Hewitt W, Mathur A, Reddy S, Moss A, Segev D, Singer A. Batra R, et al. Among authors: segev d. Exp Clin Transplant. 2015 Apr;13 Suppl 1:9-12. Exp Clin Transplant. 2015. PMID: 25894120

2

Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts.

Locke JE, Warren DS, Singer AL, Segev DL, Simpkins CE, Maley WR, Montgomery RA, Danovitch G, Cameron AM. Locke JE, et al. Transplantation. 2008 Apr 15;85(7):935-42. doi: 10.1097/TP.0b013e318168476d. Transplantation. 2008. PMID: 18408571

3

Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.

Locke JE, Warren DS, Dominici F, Cameron AM, Leffell MS, McRann DA, Melancon JK, Segev DL, Simpkins CE, Singer AL, Zachary AA, Montgomery RA. Locke JE, et al. J Am Soc Nephrol. 2008 Oct;19(10):2011-9. doi: 10.1681/ASN.2008010078. Epub 2008 Jul 23. J Am Soc Nephrol. 2008. PMID: 18650478 Free PMC article.

4

The high-risk donor: viral infections in solid organ transplantation.

Singer AL, Kucirka LM, Namuyinga R, Hanrahan C, Subramanian AK, Segev DL. Singer AL, et al. Curr Opin Organ Transplant. 2008 Aug;13(4):400-4. doi: 10.1097/MOT.0b013e3283094ba3. Curr Opin Organ Transplant. 2008. PMID: 18685336 Review.

5

Utilization and outcomes of kidney paired donation in the United States.

Segev DL, Kucirka LM, Gentry SE, Montgomery RA. Segev DL, et al. Transplantation. 2008 Aug 27;86(4):502-10. doi: 10.1097/TP.0b013e3181812f85. Transplantation. 2008. PMID: 18724216

6

Successful three-way kidney paired donation with cross-country live donor allograft transport.

Montgomery RA, Katznelson S, Bry WI, Zachary AA, Houp J, Hiller JM, Shridharani S, John D, Singer AL, Segev DL. Montgomery RA, et al. Among authors: segev dl. Am J Transplant. 2008 Oct;8(10):2163-8. doi: 10.1111/j.1600-6143.2008.02347.x. Am J Transplant. 2008. PMID: 18828774 Free article.

7

Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation.

Stewart ZA, Cameron AM, Singer AL, Dagher NN, Montgomery RA, Segev DL. Stewart ZA, et al. Among authors: segev dl. Am J Transplant. 2009 Jan;9(1):217-21. doi: 10.1111/j.1600-6143.2008.02449.x. Epub 2008 Nov 4. Am J Transplant. 2009. PMID: 18986383 Free article.

8

Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death.

Stewart ZA, Cameron AM, Singer AL, Montgomery RA, Segev DL. Stewart ZA, et al. Among authors: segev dl. Am J Transplant. 2009 Feb;9(2):286-93. doi: 10.1111/j.1600-6143.2008.02478.x. Epub 2008 Nov 27. Am J Transplant. 2009. PMID: 19067658 Free article.

9

Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs.

Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Kucirka LM, et al. Among authors: segev dl. Am J Transplant. 2009 Mar;9(3):629-35. doi: 10.1111/j.1600-6143.2008.02523.x. Epub 2008 Feb 3. Am J Transplant. 2009. PMID: 19191765 Free article.

10

Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs.

Kucirka LM, Alexander C, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Kucirka LM, et al. Among authors: segev dl. Am J Transplant. 2009 Mar;9(3):620-8. doi: 10.1111/j.1600-6143.2008.02522.x. Epub 2009 Feb 3. Am J Transplant. 2009. PMID: 19191766 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

962 results

Search Page

Filters